119 related articles for article (PubMed ID: 37955536)
1. Potential significance of podoplanin immunohistochemical expression in papillary thyroid carcinoma.
Khalil RM; El Badawy NM; Osman WM; Shash LS; Hafez FS
Pol J Pathol; 2023; 74(3):171-181. PubMed ID: 37955536
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
[TBL] [Abstract][Full Text] [Related]
3. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
Eloy C; Santos J; Soares P; Sobrinho-Simões M
Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
5. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
6. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Kurozumi K; Nakahara M; Nakao K; Kakudo K
J Clin Pathol; 2006 Jan; 59(1):77-82. PubMed ID: 16394285
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic endothelial cancerization in papillary thyroid carcinoma: hidden evidence of lymphatic invasion.
Mai KT; Truong LD; Ball CG; Olberg B; Lai CK; Purgina B
Pathol Int; 2015 May; 65(5):220-30. PubMed ID: 25722068
[TBL] [Abstract][Full Text] [Related]
8. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma.
Yasuoka H; Nakamura Y; Zuo H; Tang W; Takamura Y; Miyauchi A; Nakamura M; Mori I; Kakudo K
Mod Pathol; 2005 Aug; 18(8):1127-33. PubMed ID: 15803188
[TBL] [Abstract][Full Text] [Related]
9. The role of podoplanin in the biology of differentiated thyroid cancers.
Rudzińska M; Gaweł D; Sikorska J; Karpińska KM; Kiedrowski M; Stępień T; Marchlewska M; Czarnocka B
PLoS One; 2014; 9(5):e96541. PubMed ID: 24797369
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH
Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283
[TBL] [Abstract][Full Text] [Related]
12. Potential role of M2 TAMs around lymphatic vessels during lymphatic invasion in papillary thyroid carcinoma.
Kabasawa T; Ohe R; Aung NY; Urano Y; Kitaoka T; Tamazawa N; Utsunomiya A; Yamakawa M
Sci Rep; 2021 Jan; 11(1):1150. PubMed ID: 33441903
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions.
Garcia EA; Simões K; Wakamatsu A; Ressio RA; Alves VA; Longatto-Filho A; Camargo RS
Endocr Pathol; 2010 Jun; 21(2):101-7. PubMed ID: 20336393
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhu L; Zhang X; Zhang S; Zhang Q; Cao L; Zhang Y; Wang D; Liang X; Wu W; Wu S; Jiang R; Liu Y; Zhao X; Zhou G; Xu K; Meng Z
Clin Exp Med; 2023 Oct; 23(6):2209-2220. PubMed ID: 36715834
[TBL] [Abstract][Full Text] [Related]
16. REGγ Is Associated with Lymph Node Metastasis and T-Stage in Papillary Thyroid Carcinoma.
Qi L; He W
Med Sci Monit; 2018 Mar; 24():1373-1378. PubMed ID: 29509725
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Wu G; Zhou Y; Li T; Guo J; Zhou Z
J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
